Pharmacokinetics and potency of progestins used for hormone replacement therapy and contraception

被引：52
|
作者：
Stanczyk F.Z. [1 ]
机构：
[1] Department of Obstetrics, University of Southern California, Keck School of Medicine, Los Angeles
来源：
Reviews in Endocrine and Metabolic Disorders | 2002年 / 3卷 / 3期
关键词：
Classification; Pharmacokinetics; Potency; Progestrins; Structure-function relationships;
D O I：
10.1023/A:1020072325818
中图分类号：
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：211 / 224
页数：13
相关论文
共 50 条
  • [31] Effects of hormone replacement therapy regimens on mammographic breast density: The role of progestins
    Topal, Naile Bolca
    Ayhan, Serdal
    Topal, Ugur
    Bilgin, Tufan
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, 2006, 32 (03) : 305 - 308
  • [32] HORMONE REPLACEMENT THERAPY - SHOULD BE USED SELECTIVELY
    STEVENSON, JC
    BAUM, M
    BRITISH MEDICAL JOURNAL, 1994, 309 (6948): : 191 - 191
  • [33] Investigating the anti-mineralocorticoid properties of synthetic progestins used in hormone therapy
    Africander, Donita
    Louw, Renate
    Hapgood, Janet P.
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2013, 433 (03) : 305 - 310
  • [34] Insights on estetrol, the native estrogen: from contraception to hormone replacement therapy
    Battipaglia, Christian
    Genazzani, Alessandro D.
    Nappi, Rossella E.
    La Marca, Antonio
    MINERVA OBSTETRICS AND GYNECOLOGY, 2024,
  • [35] Sex hormones and venous thromboembolism - from contraception to hormone replacement therapy
    Beyer-Westendorf, Jan
    Bauersachs, Rupert
    Hach-Wunderle, Viola
    Zotz, Rainer B.
    Rott, Hannelore
    VASA-EUROPEAN JOURNAL OF VASCULAR MEDICINE, 2018, 47 (06) : 441 - 450
  • [36] Introduction: Structure-function relationships, metabolism, pharmacokinetics and potency of progestins
    Stanczyk, FZ
    DRUGS OF TODAY, 1996, 32 : 1 - 14
  • [37] How long should hormone replacement therapy be used?
    Jamin, C
    CONTRACEPTION FERTILITE SEXUALITE, 1999, 27 (03): : 187 - 190
  • [38] Should hormone replacement therapy be used in postmenopausal dysfunction?
    Stothers, Lynn
    CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL, 2009, 3 (02): : 150 - 152
  • [39] Impact of Hormone Therapy for Women Aged 35 to 65 Years, From Contraception to Hormone Replacement
    Kase, Nathan G.
    GENDER MEDICINE, 2009, 6 : 37 - 59
  • [40] Characterisation of progestins used in hormonal contraception and progesterone via the progesterone receptor
    Enfield, Kim
    Cartwright, Meghan
    Louw-du Toit, Renate
    Avenant, Chanel
    Africander, Donita
    Hapgood, Janet P.
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2020, 533 (04) : 879 - 885
12345